Proven industry leader will drive company growth through operational efficiencies and a focus on best-in-class delivery.

NEW YORK, NY – January 30, 2024 – Jumo Health, a global provider of age-appropriate, culturally relevant medical education resources, today announced that it has appointed Snev Dorsonne as its Chief Operating Officer to enhance its overall business operations and delivery model.

With 25 years of business operations leadership and change management experience, Dorsonne brings a wealth of expertise in driving revenue and operational efficiencies to her new role. Before joining Jumo Health, Dorsonne was President at Link9, a full-service healthcare production agency owned by Omnicom Health Group, where she expertly orchestrated the seamless production and delivery of healthcare communications programs for over 150 brands and over 70 therapeutic categories. Her successful tenure at Link9 included collaborations across 17 Omnicom Health Group agencies to craft efficient operating models and provide centralized production solutions customized for the unique requirements of over 40 manufacturers.

“Snev was brought to our attention based on her operational experience, industry knowledge, and empowering leadership style, which is a natural fit within our corporate culture and long term goals,” said Kevin Aniskovich, President and CEO of Jumo Health. “Given the scale our organization has achieved over the past several years, we were searching for a leader with an established track record of ushering in productivity improvements and managing the associated organizational change. We are thrilled that Snev selected Jumo Health and will lend her unique perspective to our collective IQ.”

In this role, Dorsonne will strategically align resources and establish robust processes to maximize efficiencies, enhance production timelines, and ensure the continuous delivery of best-in-class clinical trial solutions.

“I’m thrilled to be part of a company that is deeply committed to diversity and inclusion in all aspects,” said Dorsonne. “It’s an honor to lead this incredibly talented team of individuals who share a passion for transforming complex medical information into actionable, culturally relevant, and age-appropriate resources. I eagerly anticipate contributing to Jumo Health’s ongoing initiatives to enhance diversity in clinical trials as a member of the leadership team.”

Prior to Link9, Dorsonne served as Group Director for W2O Group (now Real Chemistry), where she shaped operational strategy, enhanced business performance, and successfully integrated multiple agency brands globally and domestically. Additionally, as Senior Vice President, Director of Workflow Systems at AgencyRx (now DDB Health) she established effective procedures for new product launches and led the development of a scalable cross-functional creative services group to support agency growth.